# Clinical Trial of PCV24 in Adults

> **NCT06474377** · PHASE1 · COMPLETED · sponsor: **Sinovac Life Sciences Co., Ltd.** · enrollment: 170 (actual)

## Conditions studied

- Pneumococcal Infectious Disease

## Interventions

- **BIOLOGICAL:** Sinovac PCV24 formulation 1
- **BIOLOGICAL:** Sinovac PCV24 formulation 2
- **BIOLOGICAL:** Pneumovax®
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06474377
- **Lead sponsor:** Sinovac Life Sciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-21
- **Primary completion:** 2024-08-26
- **Final completion:** 2025-02-26
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06474377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06474377, "Clinical Trial of PCV24 in Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06474377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*